This portion of our website contains archival information. Archived information should be considered accurate only as of the date listed next to the event. Archived information may be superseded by more recent information we have disclosed in later presentations, press releases, filings with the Securities and Exchange Commission or otherwise. Archived information may contain forward-looking statements. Actual results may materially differ based on several factors, including those described in the archived information, press releases and our filings with the SEC.
2010 | 2009 | 2008 | 2007 | 2006 |
- February 11, 2010
Targacept Reports Fourth Quarter and 2009 Financial Results - February 08, 2010
Targacept Awarded a Grant from The Michael J. Fox Foundation to Conduct Biomarker Research for Parkinson's Disease - February 04, 2010
Targacept to Report Fourth Quarter and 2009 Financial Results on February 11, 2010 - February 02, 2010
Targacept to Present at BIO CEO & Investor Conference - January 11, 2010
Targacept Receives $200 Million Upfront Payment from AstraZeneca